Sarda Proteins Ltd reported a significant turnaround, moving from a net loss of ₹0.49 crore to a profit of ₹1.66 crore in the June 2026 quarter. Revenue also saw an increase to ₹12.99 crore.
Sarda Proteins Ltd Turns Profitable in June Quarter
Sarda Proteins Ltd reported a net profit of ₹1.66 crore for the quarter ended June 30, 2026, marking a strong turnaround from a net loss of ₹0.49 crore in the same period last year. The company's revenue from operations increased to ₹12.99 crore, up from ₹10.95 crore in the prior year's corresponding quarter.
Reader Takeaway: Profit turnaround driven by revenue growth; new office and director appointment signal expansion.
What just happened
Sarda Proteins Ltd has announced its financial results for the quarter ending June 30, 2026. The company achieved a net profit of ₹1.66 crore, a significant improvement from the net loss of ₹0.49 crore reported in the June 2025 quarter. Revenue from operations grew to ₹12.99 crore from ₹10.95 crore year-on-year.
Why this matters
This shift to profitability is a key indicator of improved operational efficiency and market demand for Sarda Proteins' products. The revenue growth demonstrates an expansion of its business. The company also announced corporate developments including a new office and an independent director appointment.
The backstory
In the June 2025 quarter, Sarda Proteins Ltd was in a loss-making position. The current quarter's performance signifies a successful recovery and growth phase for the company.
What changes now
The company's transition to profitability may boost investor confidence. The establishment of a new corporate office and board appointments indicate a focus on expansion and governance.
Risks to watch
While the results are positive, continued revenue growth and sustained profitability will be crucial. The company operates in the renewable energy sector, which can be subject to policy changes and market volatility.
Peer comparison
Sarda Proteins operates within the "Renewable Energy Sector Solar Cell Products" segment. Performance benchmarks against peers in this niche sector will offer further insight into its competitive positioning.
Context metrics (time-bound)
- Revenue: ₹12.99 crore (Q1 FY27) vs ₹10.95 crore (Q1 FY26)
- Net Profit: ₹1.66 crore (Q1 FY27) vs -₹0.49 crore (Q1 FY26)
- EPS: ₹1.85 (Q1 FY27) vs -₹2.86 (Q1 FY26)
What to track next
Investors will be keen to observe the company's ability to maintain this growth trajectory in subsequent quarters and the impact of its new office and board appointments on its operations.